Hybrid and molecular tumor imaging

We were the first center, which developed and introduced internationally hybrid imaging in clinical routine. A big focus therefore still lies in the further development of hybrid molecular imaging, which has occupied a central place particular in tumor diagnosis. Currently we are at forefront working on the newest technology, the Time-of-flight PET / MRI.

In several projects, we investigate new technologies (radiopharmaceutical substances, representation of tumor metabolism and tumor perfusion, image reconstruction or new MRI sequences) to improve the visualization of various tumor diseases. The aim is to efficiently and economically employ the proper method at the right time.

Besides our technology optimizing research, we also work closely with the various clinics of the University Hospital Zurich, in order to help answering clinically relevant questions with our technologies and facilities.

Contact person
Tel. +41 44 255 15 02


Hannes Grünig MD
Martin Hüllner MD
Prof. Lars Husmann MD
Alexander Maurer MD
Michael Messerli MD

We use cookies to make our website user-friendly, to continuously improve it and to analyze the traffic of our website. By continuing to browse the site, you are agreeing to our use of cookies. Further information can be found in our privacy policy.